Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Immediate Effects of Whole-Body Vibration on Neuromuscular Performance and Postural Control in Elderly

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03356418
Recruitment Status : Completed
First Posted : November 29, 2017
Last Update Posted : June 18, 2019
Sponsor:
Information provided by (Responsible Party):
Jamilson Simões Brasileiro, Universidade Federal do Rio Grande do Norte

Brief Summary:
The purpose of this study is to analyze the immediate effects of an exercise protocol on the vibration platform on the functional and neuromuscular performance of lower limbs, postural control and life quality in healthy elderly.

Condition or disease Intervention/treatment Phase
Neuromuscular Performance and Balance Other: WBV exercise group Other: Sham WBV exercise group Not Applicable

Detailed Description:
The research is a randomized controlled trial that will be developed at the Laboratório de Análise da Performance Muscular (LAPERN) of the Physiotherapy Department of the Federal University of Rio Grande do Norte (UFRN). The population of the present study will be formed by elderly individuals living in the city of Natal / RN, aged between 65 and 75 years, of both sexes, without distinction of race, education and marital status. The research sample will be of a non-probabilistic type, in which these will be allocated randomly into two distinct groups: placebo group (GP) and experimental group (GE). This research was submitted to the Research Ethics Committee (CEP) for UFRN through the national interface Plataforma Brasil. The present research contemplates the ethical aspects based on Resolution 466/2012 of the National Health Council (CNS) and the Declaration of Helsinki for research with humans. In addition, the survey will be recorded in Clinicals Trial. All data will be recorded in a database of the laboratory under confidentiality and can only be handled by the responsible researchers. The study will only begin after the issuance of the referent opinion approving the project. All subjects will be duly informed and instructed regarding the scheduled procedures, which will only be executed after reading, accepting and signing the Term of Free and Informed Consent (TFIC). After approval by the Research Ethics Committee, following resolution 466/2012, a pilot study was carried out aiming at the adequacy of all the research procedures, as well as the training of the researchers involved. Initially the research will begin with the selection of the sample according to the inclusion criteria descried elsewhere. The evaluation will be scheduled by telephone contact. Following this, the volunteers will receive the TFIC for reading and due signature. The data collection process will take place in four stages: (1) initial evaluation, (2) sample allocation (3) application of exercise program and (4)reevaluation. The evaluations will be composed by the dynamometric analysis associated with EMG (electromyography) and postural control analysis. The volunteers will be allocated randomly into 2 groups: placebo group (with the platform off) or experimental group (with the platform set at a frequency of 40 Hz and amplitude of 4 mm). Both will perform a bout of exercise in the vibrating platform, consisting of a static bipodal squat at 40 ° of knee flexion, with 4 sets of 1.5 min, with a rest interval of 1 minute. Immediately after the exercise the volunteers will be submitted to a revaluation, with the same procedures of the initial evaluation.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Immediate Effects of Whole-Body Vibration on Neuromuscular Performance and Postural Control in Elderly: A Randomized Controlled Trial
Actual Study Start Date : March 10, 2018
Actual Primary Completion Date : April 10, 2018
Actual Study Completion Date : May 10, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: WBV exercise group
Subjects will perform an isometric semi-squat exercise associated with the vibratory platform. The exercise will consist of 4 series of an isometric half-squat exercise with 1 minute and a half of duration and a rest interval of 1 minute. The vibratory platform will be connected at the beginning of each series, set at a vibration frequency of 40 Hertz (Hz) and peak-to-peak amplitude of 4 millimeters (mm) resulting in a peak acceleration of 128 ms2 (12.8 g). This should provide the equivalent of 3600 vertical vibrations, totaling 14400 vibrations per training session
Other: WBV exercise group
The intervention will consist of a half-squat isometric whole-body vibration exercise with the platform configured at a frequency of 40 Hz and peak-to-peak amplitude of 4 mm. The sessions will be held 2 times a week, consisting of 4 sets of 1 and a half minutes of exercise on the platform. Rest intervals of 1 minute between sets will be respected.

Sham Comparator: Sham WBV exercise group
Subjects will perform an isometric semi-squat exercise associated with the vibratory platform. The exercise will consist of 4 series of an isometric half-squat exercise with 1 minute and a half of duration and a rest interval of 1 minute. The vibratory platform will remain off at all sessions. A device will be attached to the side of the platform in order to produce a sound, similar to the sound produced by the vibrating platform when it is in operation.
Other: Sham WBV exercise group
The intervention will consist of as half-squat isometric exercise , but the platform will remain off at all sessions. A device will be attached to the side of the platform in order to produce a sound, similar to the sound produced by the vibrating platform when it is in operation.




Primary Outcome Measures :
  1. Change in average power measured through isokinetic dynamometer [ Time Frame: Baseline and immediately after the intervention protocol. ]
    Measured through isokinetic dynamometry. The analyzed variable will be average power (in watts).


Secondary Outcome Measures :
  1. Change in Muscle activation measured through surface electromyography [ Time Frame: Baseline and immediately after the intervention protocol. ]
    Measured by surface electromyography. The analyzed variable will be the amplitude of muscle activation (in microvolts).

  2. Change in Balance measured through baropodometry [ Time Frame: Baseline and immediately after the intervention protocol . ]
    Measured by baropodometry. The analyzed variable will be the oscilation of center of pressure (in mm).

  3. Change in peak torque normalized by body weight measured through isokinetic dynamometer [ Time Frame: Baseline and immediately after the intervention protocol. ]
    Measured through isokinetic dynamometry. The analyzed variable will be a combination of peak torque normalized by body weight (in percentage).

  4. Change in total work measured through isokinetic dynamometer [ Time Frame: Baseline and immediately after the intervention protocol. ]
    Measured through isokinetic dynamometry. The analyzed variable will be total work (in joules).

  5. Change in peak torque measured through isokinetic dynamometer [ Time Frame: Baseline and immediately after the intervention protocol. ]
    Measured through isokinetic dynamometry. The analyzed variable will be peak torque (in Newtons).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years to 75 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Both genders;
  • Exhibiting ankle, hip and knee joint integrity of the non-dominant limb;
  • No history of muscle or joint injuries in the assessed limb in the last 6 months, or neurological, visual and/or non-corrected auditory impairments;
  • Do not have metallic implants in the lower limbs;
  • Do not have decompensated and / or untreated cardiovascular diseases;
  • Do not have advanced osteoporosis;
  • Do not have neurodegenerative diseases;
  • Do not have vestibular disorders;
  • Do not have uncorrected visual or hearing deficits.

Exclusion Criteria:

  • Elderly classified as very active or active;
  • Report cardiac and / or respiratory discomfort, nausea, vertigo and pain during during the evaluations and exercise sessions;
  • Do not understand and do not correctly perform the commands offered in the assessment and / or intervention protocols;

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03356418


Locations
Layout table for location information
Brazil
Federal University of Rio Grande do Norte (UFRN)
Natal, RN, Brazil, 59140-840
Sponsors and Collaborators
Universidade Federal do Rio Grande do Norte
Investigators
Layout table for investigator information
Principal Investigator: Daniel T Borges, MS Universidade Federal do Rio Grande do Norte
Principal Investigator: Lidiane C Bulhões, Esp Universidade Federal do Rio Grande do Norte
Layout table for additonal information
Responsible Party: Jamilson Simões Brasileiro, Associeted Professor and Researcher, Universidade Federal do Rio Grande do Norte
ClinicalTrials.gov Identifier: NCT03356418    
Other Study ID Numbers: DL2017.2
First Posted: November 29, 2017    Key Record Dates
Last Update Posted: June 18, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jamilson Simões Brasileiro, Universidade Federal do Rio Grande do Norte:
Exercise
Vibration
Torque
Aging